Related Experiment Video
Updated: Jan 6, 2026

11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
14.3K
Detecting Heparin Contamination in Prolonged APTT with a Heparin-Resistant Solution
Elizabeth Crosby1, Thomas Exner2, Manita Dangol2
1Welsh Blood Service, Aneurin Bevan UHB Pathology, Grange University Hospital, Cardiff Metropolitan University, Wales, UK.
Summary
A new reagent, Antihepca HRRS, effectively neutralizes unfractionated heparin (UFH) interference in activated partial thromboplastin time (APTT) testing. This solution helps distinguish true coagulation pathology from heparin contamination in clinical laboratories.
Area of Science:
- Clinical Chemistry
- Hematology
- Laboratory Medicine
Background:
- Activated partial thromboplastin time (APTT) is crucial for coagulation assessment.
- Prolonged APTT can stem from pathology or unfractionated heparin (UFH) contamination.
- Differentiating true pathology from heparin interference is vital for patient care.
Purpose of the Study:
- To evaluate the efficacy of Antihepca HRRS (AHCa), a Heparin Resistant Recalcifying Solution (HRRS), in neutralizing heparin interference in APTT assays.
- To assess AHC a's impact on APTT results in both heparinized and non-heparinized patient samples.
- To determine the neutralization limit of AHC a for UFH.
Main Methods:
- APTT testing was performed using AHC a HRRS and standard CaCl2 on Sysmex CN-6000 and Stago Start Max analyzers.
- Samples included 33 heparinized, 41 non-heparinized, and 30 random prolonged APTT patient plasmas.
- Heparin-spiked plasmas were used to establish the UFH neutralization limit of AHC a.
Main Results:
- AHCa HRRS corrected prolonged APTT in samples with UFH up to 0.6 IU/mL.
- In heparinized samples, AHC a reduced APTT to <40 s, simplifying reporting.
- AHCa corrected 8 of 30 prolonged APTT samples, indicating heparin, while 20 suggested other causes.
Conclusions:
- AHCa HRRS effectively neutralizes UFH interference in APTT testing.
- AHCa demonstrates minimal impact on APTT results in non-heparinized samples, preserving accuracy.
- AHCa offers a practical alternative for identifying heparin contamination in clinical labs.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
254
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
254

